STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXST
  4. [Form 4] RxSight, Inc. Insider Trading Activity

RxSight executive exchanges options at $6.375

RxSight’s chief business development officer exchanged multiple higher‑priced options for new grants at a $6.375 exercise price under the company’s option exchange program.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RxSight, Inc. reported an option exchange for Chief Business Development Officer Eric Weinberg on September 5, 2026. Several outstanding stock options were returned to the company, including grants for 87,437, 95,000, 92,200, 50,000, and 125,000 shares with exercise prices ranging from $14.95 to $56.07 per share. In connection with the issuer’s option exchange program, these were replaced with new options for 65,742, 82,608, 59,483, 32,258, and 93,984 shares at a post‑exchange exercise price of $6.375 per share, subject to time‑based vesting conditions through 2027. No Rule 10b5‑1 trading plan is reported, and all positions are held directly.

Positive

  • None.

Negative

  • None.
Insider Weinberg Eric
Role See remarks
Type Security Shares Price Value
Disposition Stock option (right to buy) F1 87,437 -- --
Disposition Stock Option (right to buy) F3, F2 95,000 -- --
Disposition Stock Option (right to buy) F5, F4 92,200 -- --
Disposition Stock Option (right to buy) F5, F6 50,000 -- --
Disposition Stock Option (right to buy) F1, F7 125,000 -- --
Grant/Award Stock Option (right to buy) F1, F8 65,742 -- --
Grant/Award Stock Option (right to buy) F3, F9 82,608 -- --
Grant/Award Stock Option (right to buy) F5, F10 59,483 -- --
Grant/Award Stock Option (right to buy) F5, F11 32,258 -- --
Grant/Award Stock Option (right to buy) F1, F12 93,984 -- --
Holdings After Transaction: Stock option (right to buy) — 334,075 contracts (Direct)
Footnotes (12)
  1. F1. On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share.
  2. F2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.
  3. F3. On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share.
  4. F4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024.
  5. F5. On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share.
  6. F6. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024.
  7. F7. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025.
  8. F8. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027.
  9. F9. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 70,560 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 70,560 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 12,048 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
  10. F10. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
  11. F11. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
  12. F12. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
Options disposed (first grant) 87,437 options Outstanding stock options returned to RxSight on September 5, 2026 at a prior $16.00 exercise price
Options disposed (additional grants) 95,000; 92,200; 50,000; 125,000 options Further outstanding options returned to the issuer on September 5, 2026
New option grants at post‑exchange price 65,742; 82,608; 59,483; 32,258; 93,984 options New options granted to Eric Weinberg on September 5, 2026 in the exchange
Post‑exchange exercise price $6.375 per share Exercise price of all exchanged options after the September 5, 2026 option exchange
Exchange ratios 1.33:1; 1.15:1; 1.55:1 Ratios at which certain outstanding options were exchanged for new options on September 5, 2026
Cliff vesting dates for new options February 28, 2027 and August 31, 2027 Many new options vest 25% on February 28, 2027 and 75% on August 31, 2027, subject to continued service
option exchange program financial
"On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option"
Vesting Commencement Date financial
""Vesting Commencement Date" shall mean March 9, 2023."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan)"
2021 Equity Incentive Plan financial
"as defined in the Issuer's 2021 Equity Incentive Plan"

FAQ

What did RxSight (RXST) disclose about Eric Weinberg’s stock options on this Form 4?
RxSight disclosed that Eric Weinberg, Chief Business Development Officer, returned several existing stock options to the company and received new stock option grants at an exercise price of $6.375 per share under an option exchange program effective September 5, 2026.

How many RxSight (RXST) options were disposed of in the exchange for Eric Weinberg?
Eric Weinberg disposed of multiple existing stock options to RxSight on September 5, 2026, including grants for 87,437, 95,000, 92,200, 50,000, and 125,000 shares, each representing rights to purchase RxSight common stock at higher exercise prices before the exchange.

What new RxSight (RXST) option grants did Eric Weinberg receive and at what exercise price?
In the option exchange, Eric Weinberg received new stock options covering 65,742, 82,608, 59,483, 32,258, and 93,984 shares of RxSight common stock, all with a post‑exchange exercise price of $6.375 per share, subject to vesting conditions.

How does the RxSight (RXST) option exchange program affect vesting for Eric Weinberg’s new options?
The filing states that the new options vest over time, often with one forty‑eighth of the shares vesting monthly from a defined “Vesting Commencement Date,” or with 25% vesting on February 28, 2027 and the remaining 75% on August 31, 2027, subject to continued service.

Were Eric Weinberg’s RxSight (RXST) option transactions made under a Rule 10b5‑1 plan?
The Form 4 indicates that no Rule 10b5‑1 trading plan is reported for these transactions. The option exchanges and new grants on September 5, 2026 are described in connection with RxSight’s option exchange program rather than a pre‑arranged trading plan.

What were the original exercise prices of the RxSight (RXST) options exchanged by Eric Weinberg?
The options returned to RxSight had exercise prices including $16.00, $14.95, $56.07, $46.24, and $28.21 per share. These were exchanged for new options with a $6.375 exercise price as part of the company’s option exchange program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weinberg Eric
(Last)(First)(Middle)
C/O RXSIGHT, INC.
100 COLUMBIA
(Street)
ALISO VIEJO CALIFORNIA 92656
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (right to buy)$1609/05/2026D87,43707/30/202507/30/2031Common Stock87,437(1)0D
Stock Option (right to buy)$14.9509/05/2026D95,000 (2)03/09/2033Common Stock95,000(3)0D
Stock Option (right to buy)$56.0709/05/2026D92,200 (4)03/03/2034Common Stock92,200(5)0D
Stock Option (right to buy)$46.2409/05/2026D50,000 (6)08/06/2034Common Stock50,000(5)0D
Stock Option (right to buy)$28.2109/05/2026D125,000 (7)02/26/2035Common Stock125,000(1)0D
Stock Option (right to buy)$6.37509/05/2026A65,742 (8)09/04/2033Common Stock65,742(1)65,742D
Stock Option (right to buy)$6.37509/05/2026A82,608 (9)09/04/2033Common Stock82,608(3)82,608D
Stock Option (right to buy)$6.37509/05/2026A59,483 (10)09/04/2033Common Stock59,483(5)59,483D
Stock Option (right to buy)$6.37509/05/2026A32,258 (11)09/04/2033Common Stock32,258(5)32,258D
Stock Option (right to buy)$6.37509/05/2026A93,984 (12)09/04/2033Common Stock93,984(1)93,984D
Explanation of Responses:
1. On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share.
2. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.
3. On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share.
4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024.
5. On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share.
6. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024.
7. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025.
8. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027.
9. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 70,560 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 70,560 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 12,048 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
10. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
11. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
12. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
Remarks:
Chief Business Development Officer
/s/ Jim Schindler, as Attorney-in-Fact09/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on RXST

Trending in the feed

Open the live feed